Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorLEGRAND, A.
dc.contributor.authorPUJOL, C.
hal.structure.identifierLaboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) [U1211 INSERM/MRGM]
dc.contributor.authorDURAND, Christelle
dc.contributor.authorMESNIL, A.
dc.contributor.authorRUBERA, I.
dc.contributor.authorDURANTON, C.
dc.contributor.authorZUILY, S.
dc.contributor.authorSOUSA, A.B.
dc.contributor.authorRENAUD, M.
dc.contributor.authorBOUCHER, J.L.
dc.contributor.authorPIETRANCOSTA, N.
dc.contributor.authorADHAM, S.
dc.contributor.authorORSSAUD, C.
dc.contributor.authorMARELLI, C.
dc.contributor.authorCASALI, C.
dc.contributor.authorZICCARDI, L.
dc.contributor.authorVILLAIN, N.
dc.contributor.authorEWENCZYK, C.
dc.contributor.authorDURR, A.
dc.contributor.authorMIGNOT, C.
dc.contributor.authorSTEVANIN, G.
dc.contributor.authorBILLON, C.
dc.contributor.authorHUREAUX, M.
dc.contributor.authorJEUNEMAITRE, X.
hal.structure.identifierLaboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) [U1211 INSERM/MRGM]
dc.contributor.authorGOIZET, Cyril
dc.contributor.authorALBUISSON, J.
dc.date.accessioned2021-10-26T13:34:04Z
dc.date.available2021-10-26T13:34:04Z
dc.date.issued2021
dc.identifier.issn0954-6820 (print) 1365-2796 (online)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/113321
dc.description.abstractEnPurpose: Pseudoxanthoma elasticum (PXE) is a recessive disorder involving skin, eyes and arteries, mainly caused by ABCC6 pathogenic variants. However, almost one fifth of patients remain genetically unsolved despite extensive genetic screening of ABCC6, as illustrated in a large French PXE series of 220 cases. We searched for new PXE gene(s) to solve the ABCC6-negative patients. Methods: First, family-based exome sequencing was performed, in one ABCC6-negative PXE patient with additional neurological features, and her relatives. CYP2U1, involved in hereditary spastic paraplegia type 56 (SPG56), was selected based on this complex phenotype, and the presence of two candidate variants. Second, CYP2U1 sequencing was performed in a retrospective series of 46 additional ABCC6-negative PXE probands. Third, six additional SPG56 patients were evaluated for PXE skin and eye phenotype. Additionally, plasma pyrophosphate dosage and functional analyses were performed in some of these patients. Results: 6.4% of ABCC6-negative PXE patients (n = 3) harboured biallelic pathogenic variants in CYP2U1. PXE skin lesions with histological confirmation, eye lesions including maculopathy or angioid streaks, and various neurological symptoms were present. CYP2U1 missense variants were confirmed to impair protein function. Plasma pyrophosphate levels were normal. Two SPG56 patients (33%) presented some phenotypic overlap with PXE. Conclusion: CYP2U1 pathogenic variants are found in unsolved PXE patients with neurological findings, including spastic paraplegia, expanding the SPG56 phenotype and highlighting its overlap with PXE. The pathophysiology of ABCC6 and CYP2U1 should be explored to explain their respective role and potential interaction in ectopic mineralization.
dc.language.isoENen_US
dc.subject.enABCC6
dc.subject.enCYP2U1
dc.subject.enEctopic mineralization
dc.subject.enHereditary spastic paraplegia type 56
dc.subject.enPseudoxanthoma elasticum
dc.title.enPseudoxanthoma elasticum overlaps hereditary spastic paraplegia type 56
dc.typeArticle de revueen_US
dc.identifier.doi10.1111/joim.13193en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
dc.identifier.pubmed33107650en_US
bordeaux.journalJournal of Internal Medicineen_US
bordeaux.page709-725en_US
bordeaux.volume289en_US
bordeaux.hal.laboratoriesMaladies Rares : Génétique et Métabolisme (MRGM) - UMR 1211en_US
bordeaux.issue5en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDAssistance Publique - Hôpitaux de Parisen_US
bordeaux.identifier.funderIDInstitut National de la Santé et de la Recherche Médicaleen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Internal%20Medicine&rft.date=2021&rft.volume=289&rft.issue=5&rft.spage=709-725&rft.epage=709-725&rft.eissn=0954-6820%20(print)%201365-2796%20(online)&rft.issn=0954-6820%20(print)%201365-2796%20(online)&rft.au=LEGRAND,%20A.&PUJOL,%20C.&DURAND,%20Christelle&MESNIL,%20A.&RUBERA,%20I.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée